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Abstract 
Hospitals are intended to heal the sick; but they are also sources of infection. Ironically, the advances in 
medicine are partly responsible for the fact that today; hospital infections are the leading cause of death 
worldwide. Newer technology and latest surgical and medical diagnostic methods and treatment 
procedures have increased the number of invasive techniques leading to higher chances of nosocomial 
infection. Pneumonia is the leading cause of death due to nosocomial infections. Intubation & mechanical 
ventilation greatly increases the risk for ventilator-associated pneumonia (VAP). In developing country 
like India, such hospital-acquired infections have a significant impact on patient’s morbidity, mortality, 
hospital stay and on financial concerns of the patient, hospital and community. The present investigation 
was aimed to determine the incidence of ventilator associated pneumonia in the neurosurgery intensive 
care unit of a tertiary care centre and to determine the risk factors of ventilator associated pneumonia. A 
total of 30 samples belonging to the age group of 15 to 75 years who where on mechanical ventilator for 
more than 48 hours in the neurosurgery intensive care unit of a tertiary care centre were selected using 
convenience sampling. The incidence of VAP was estimated to be 30%. The risk factors identified for the 
development of VAP was found to be combined head and cervical spine injury (P=0.001), associated 
injuries (P=0.035), additional surgeries (P=0.025), nasogastric feeding (P=0.001), intake of immuno 
suppressive drugs (P=0.004), pre operative antibiotics (p=0.000) and duration of mechanical ventilation >5 
days (P=0.000). The mortality among patients with VAP was found to be higher than patients without VAP 
(88.9% than non VAP patients). 
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Introduction 
Nosocomial infections, even in this modern 
era of antibiotics, continue to remain an important 
and formidable consequence of hospitalization. 
New technology and latest surgical and medical 
diagnostic methods and treatment procedures have 
increased the number of invasive techniques 
leading to higher chances of nosocomial infection. 
Nosocomial infections have a significant 
impact on patient’s mortality, morbidity, hospital 
stay and on the financial concerns of patients, 
hospital and community. The National 
Nosocomial Infection Surveillance System 
database compiled by the CDC shows that 3.5% of 
patients leave hospital after having acquired 
infection, depending on the cause, hospital size 
and multiple other factors (NNIS 2006). The 3 
most common invasive device related infections 
are central line associated blood stream infection 
(BSI), ventilator associated pneumonia (VAP) and 
Foley’s catheter associated urinary tract infection.  
These infections occur most commonly in those 
who are cared in intensive care units (CDC, 2006). 
Device associated nosocomial infection rate in 
Intensive Care Units of the university affiliated 
hospital in Greece demonstrated 12.1 infections 
per 1,000 device days for BSI and ventilator 
associated pneumonia to be 12.5 infections per 
1,000 device days (Sofia, Dima  and Evangelos, 
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2007). Nosocomial infections are notorious for the 
manner in which they complicate the course of the 
original illness, increase costs of hospital stay and 
delay recovery 10 to 30 percent of patients 
admitted to hospitals & nursing homes in India 
acquire nosocomial infection as against 5% in the 
west and a very large number of Indians are every 
year under the threat of nosocomial infection. Here 
hospital acquired infections kill more people than 
any other form of accidental death (Yohan & 
Mishra ,2006).The invariable outcome is antibiotic 
intake costing between Rs.3000 to Rs 5000 a day 
(1.2 – 1.5 lakhs over & above the actual treatment 
cost) prolonged hospital stay & loss of work, 
which affects the health of the economy too 
(WHO 2005). However infection control in the 
hospitals is far from encouraging. So, the present 
investigation was aimed to determine the 
incidence of ventilator associated pneumonia in 
the neurosurgery intensive care unit of a tertiary 
care centre and to determine the risk factors of 
ventilator associated pneumonia. 
Materials and methods 
Research Approach 
A descriptive approach was used to 
accomplish the objectives 
Research Design 
The design adopted for the present study was 
descriptive survey 
Sample 
A total of 30 samples, both male & female 
patients who were selected on the basis of 
selection criteria. 
Sampling technique 
In this study, convenience sampling technique 
was adopted. 
Criteria for sample selection 
This study, the following criteria were set to 
include the samples in the study. 
1. Patients who were admitted in the 
Neurosurgery intensive care unit and those 
who required mechanical ventilation for 
more than 48 hours. 
2. Patients who were free of respiratory tract 
infection at the time of surgery. 
3. Patients of age between 15 and 75 years. 
Tool I: General assessment profile  
a) Demographic data: This consisted of 
information regarding patient’s age & sex. 
b) Clinical data: This included information 
regarding clinical diagnosis, nature of airway, co-
morbid illness, presence of nasogastric feeding, 
type of peptic ulcer disease prophylaxis, treatment 
with immunosuppressive drug and presence of pre 
operative antibiotics. 
Tool II: Investigation report 
a). Report of chest X -ray 
b).Report of endo tracheal aspirate culture (both 
qualitative & quantitative) 
Tool III: Check list for clinical assessment of 
ventilator associated pneumonia: 
This included the assessment of following 
parameters- fever (>37.8◦C), hypothermia 
(<36◦C), leucocytosis (>12,000/mm3), 
leucopenia<4000/mm3), new onset of purulent 
tracheal secretion and rales /bronchial breath 
sounds. 
Data collection process 
The investigator selected patients according to 
the inclusion criteria. The patients  /their 
relatives were given explanation regarding the 
purpose of the study and informed consent was 
taken before the study. 
Demographic data and clinical data were 
collected pre operatively from the neurosurgical 
patients who were admitted in the general wards 
and trauma care unit of using the assessment 
format .Patients were assessed clinically and 
radiologically to exclude pre existing respiratory 
tract infection. Post operatively, same patients 
were assessed in the neurosurgery intensive care 
unit for the clinical and radiological evidence for 
the development of ventilator associated 
pneumonia starting after 48 hours of mechanical 
ventilation till 2 days after extubation with the 
help of assessment format. 
Results  
Findings related to general assessment of the 
patients - demographic and clinical data  
a) Demographic characteristics  
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Table 1. Frequency distribution and percentage of 
patients according demographic characteristics age 
and sex (n=30)  
Demographic data f % 
 Age in years   
20-30 7 23.3 
31-40 3 10 
41-50 8 26.7 
51-60 9 30 
61-70 3 10 
 Sex   
Male 20 66.7 
Female 10 33.3 
The data presented in table 2  show that 10 % 
of patients belong to age group 61-70 years, 30% 
of patients belong to age group of 51-60 years 
followed by 41-50 years (26.7%),31-40 years (10 
%) & 20 -30 years( 23.3 %). It was observed that 
majority of patients i.e., 66.7% were males.  
b) Clinical data  
Table 2. Frequency distribution and percentage of 
patients according to clinical data (n=30)  
Clinical data f % 
Diagnosis    
Head injury  18 60 
Intra cranial space occupying lesion  6 20 
Intracerebral hemorrhage  2 6.7 
Head and cervical spine injury  4 13.3 
Co-morbid illness    
Bronchial asthma  1 3.33 
Chronic obstructive pulmonary disease  1 3.33 
Diabetes mellitus 2 6.66 
Hypertension  3 10 
Associated injuries  4 13.33 
Additional surgery  2 6.66 
Nasogastric feeding    
Present  13 43.3 
Absent  17 56.7 
Treatment with immuno suppressive drug    
Present  9 70 
Absent  21 30 
Administration of pre-operative antibiotics     
Present  12 40 
Absent  18 60 
Peptic ulcer prophylaxis   
H2 receptor antagonist 17 56.7 
Mucosal barrier fortifiers 0 0 
Proton pump inhibitors 5 16.66 
None 8 26.66 
Duration of ventilation (days)    
2-5 20 66.66 
6-10 10 33.33 
Mortality status   
Survivors 18 60 
Non survivors 12 40 
The data presented in table 3 reveal that 60% 
of patients had head injury. 20%, 13.3% & 6.7% 
were diagnosed to have intracranial space 
occupying lesion, combined head and cervical 
spine injury & intra cerebral hemorrhage 
respectively. It was observed that 13.3% of 
patients suffered associated injuries, 10% had 
history of hypertension, 6.66% underwent 
additional surgery and 6.66% had diabetes 
mellitus. Bronchial asthma and chronic obstructive 
pulmonary disease was present in 3.33% of 
patients.  
It was noted that nasogastric feeding was 
present among 43.3% of patients. 70% of patients 
were on immunosuppressive drug & 40 % on pre-
operative antibiotics. 56.7% of patients received 
H2 receptor blocker while proton pump inhibitor 
was present for 16.66 % of patients. 66.66% of 
total patients were on mechanical ventilator for a 
period of 2-5 days while 33.33% of patients were 
ventilated for time duration of 6-10 days. 40 % 
who were on mechanical ventilator expired during 
the study period while 60 % of patients survived. 
Findings of investigation in the patients - chest X-
ray, endo tracheal aspirate culture 
Table 3. Frequency distribution and percentage of 
patients according to the findings of investigation- 
chest X ray, endotracheal aspirate culture (n=30) 
Investigation f % 
Chest X-ray    
New infiltrates 8 26.7 
Consolidation  1 3.3 
Cavitations 0 0 
Normal 21 70 
Endo tracheal aspirate culture    
Positive  26 86.7 
Negative  4 13.3 
Quantitative culture  of endotracheal aspirate   
>105  cfu/ml 9 30 
<105cfu/ml  21 70 
Pathogens grown in endotracheal aspirate 
culture  
  
Pseudomonas  6 20 
Klebsiella  10 33.3 
Staphylococcus  1 3.3 
E coli 5 16.7 
Pseudomonas,& Klebsiella  1 3.3 
Pseudomonas & E coli 2 6.7 
Klebsiella, & Staphylococcus  1 3.3 
No growth  4 13.3 
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The data presented in table 3 reveal that, 
26.7% of patients developed new filtrates and 
3.3% had consolidation while on mechanical 
ventilator but none  of the patients developed 
cavitations.86.7%of patients were tested positive 
for endotracheal aspirate culture(ETA) and 30% of 
patients  met the threshold value of ETA aspirate 
i.e. >105  cfu/ml. The most frequently isolated 
organism were Klebsiella (33.3%) followed by 
Pseudomonas (20%),E coli (16.7%) and 
Staphylococcus (3.3%). 13.3% of patients had 
polymicrobial growth with Pseudomonas and E. 
coli (6.7% )while 3.3% of the patients 
demonstrated infection by Pseudomonas and 
Klebsiella and Klebsiella and Staphylococcus.  
Table 4. Frequency distribution and percentage of 
patients according to CDC criteria for diagnosis of 
ventilator associated  pneumonia (n=30) 
Clinical assessment f % 
Fever (>380C)   
Present  13 43.3 
Absent  7 23.3 
Hypothermia (<350 C)   
Present  0 0 
Absent  30 100 
Lecucocytosis    
Present  9 30 
Absent  21 70 
Leucopenia    
Present  0 0 
Absent  30 100 
Purulent secretion    
Present  20 66.7 
Absent  10 33.3 
Incidence of ventilator associated pneumonia 
Table 5. Frequency distribution and percentage of 
patients according to incidence of ventilator 
associated pneumonia (n=30) 
Ventilator associated pneumonia f % 
Present  9 30 
Absent  21 70 
Fig: 1 Pie diagram representing the incidence of 
ventilator associated pneumonia 
 
Table 5 and figure 1 depicts that 30% of patients 
developed ventilator associated pneumonia.  
Table 6 and figure 2 reveals that among 
patients with VAP, equal percentage (44.4%) had 
head injury and combined head & cervical spine 
injury. Intracranial space occupying lesion was 
present in 11.1 % of patients with VAP.66.7 % of 
patients without VAP  had head injury while 28.6 
% & 4.8 % had intracranial space occupying 
lesion & intracranial hemorrhage respectively. 
None had combined head & cervical spine injury.  
In order to determine the association between 
diagnosis and incidence of VAP, chi-square was 
computed. It was found that, the obtained chi 
square value for head injury, intracranial space 
occupying lesion and intracerebral hemorrhage 
was not significant (p>0.05), but it was observed 
that, the chi square value computed for  combined 
head and cervical spine injury was  statistically 
significant at 0.01 level.  
Findings related to the association between 
clinical data – Co-morbid illness & incidence of 
VAP. 
The data shown in Table 7 reveal that, among 
patients with VAP, equal percentage of patients 
(11.1 1%) had bronchial asthma, diabetes mellitus 
& hyper tension. Associated injury was present in 
3.33 % of patients & 22.2 % underwent additional 
surgery. None had history of chronic obstructive 
pulmonary disease. Among patients without VAP, 
equal percentage (4.76%) had chronic obstructive 
pulmonary disease, diabetes mellitus & associated 
injuries. Hypertension was reported in 9.52 % of 
patients without VAP & none had bronchial 
asthma or underwent additional surgery. In order 
to determine the association between co morbid 
illness and incidence of VAP, chi square test of 
significance was computed. It was found that the 
obtained chi square value for bronchial asthma, 
chronic obstructive pulmonary disease, diabetes 
mellitus and hypertension is not 
significant(p>0.05).It was found that the chi 
square computed for associated injuries and 
additional surgery was statistically significant at 
0.05 level. The risk ratio for associated injury is 
established by computing Odd’s ratio. It was 
found that, patients with associated injuries are 10 
times more prone to develop VAP than patients 
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Table 6. Frequency distribution, percentage, chi square value and ‘p’ value of clinical data –clinical 
diagnosis of patients and incidence of VAP (n=30) 
Clinical data: Diagnosis With VAP Without VAP df χ 2 ‘p’ value  f % f % 
Head injury  4 44.4 14 66.7 1 1.591 0.207 
Intracranial space occupying lesion  0 0 6 28.6 1 0.408 0.523 
Intracerebral hemorrhage  1 11.1 1 4.8 1 0.408 0.523 
Head and cervical spine injury  4 44.4 0 0 1 10.769 0.001** 
** Significant at 0.01 level. 
Fig 2: Bar diagram representing clinical data –diagnosis of the patients and incidence of VAP. 
 
Table 7. Frequency distribution, percentage, chi square value and ‘p’ value of clinical data - co morbid 
illness & incidence of VAP (n=30) 
Clinical data : 
Co-morbid illness 
With VAP Without VAP df χ 2 ‘p’ value f % f % 
Bronchial asthma  1 11.1 0 0 1 2.414 0.120 
Chronic obstructive 
pulmonary disease   0 0 1 4.76 1 0.443 0.506 
Diabetes mellitus   1 11.1 1 4.76 1 0.408 0.523 
Hypertension   1 11.1 2 9.52 1 0.018 0.894 
Associated injuries  3 33.3 1 4.76 1 4.451 0.035* 
Additional surgery  2 22.22 0 0 1 5 0.025* 
* Significant at 0.05 level. 
Table 8. Frequency distribution, percentage, chi square value and ‘p’ value of clinical data - presence of 
nasogastric feeding in the patients & incidence of VAP (n=30) 
Clinical data: 
Nasogastric feeding 
With VAP Without VAP df χ 2 ‘p’ value f % f % 
Present 8 88.9 5 23.8 1 10.866 0.001*** Absent 1 11.1 16 76.2  
*** Significant at 0.001 level. 
Table 9. Frequency distribution, percentage, chi square value and ‘p’ value of intake of immuno 
suppressive drug & incidence of VAP (n=30) 
Clinical data : Immuno suppressive 
drug 
With VAP Without VAP df χ 2 ‘P’ value f % f % 
Present 6 66.7 3 14.3 1 8.231 0.004** 
Absent 3 33.3 18 85.7    
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Findings related to the association between 
clinical data –nasogastric feeding in the patients 
& incidence of VAP.  
In order to determine association between 
clinical data –nature of feeding and incidence of 
VAP, chi square test of significance was 
computed. 
Table 8 points out that 88.9% patients who 
developed VAP was on nasogastric feeding, while 
patients who were free of VAP, 76.2% was not 
having nasogastric feeding.  
In order to determine association between 
clinical data –nasogastric feeding and incidence of 
VAP, chi square test of significance was 
computed. It was found that the obtained chi 
square value significant at 0.001 level. The risk 
ratio for associated injury is established by 
computing Odd’s ratio. It was found that, patients 
on nasogastric feeding are 25 times more prone to 
develop VAP than patients without nasogastric 
feeding. 
Findings related to the association between 
clinical data – intake of immuno suppressive drug 
patients & incidence of VAP.  
In order to determine the association between 
intake of immuno suppressive drug and incidence 
of VAP, chi square test of significance was 
computed. Table 9, reveal that all patients (100%) 
of patients who developed VAP had immuno 
suppressive drug whereas only 14.3% of patients 
without VAP had immuno suppressive drug.  
In order to determine the association between 
intake of immuno suppressive drug and incidence 
of VAP, chi square test of significance was 
computed .It was found that chi square computed 
for presence of immunosuppressive drug was 
significant at 0.001.The risk ratio for the intake of 
immunosuppressive drug is established by 
computing Odd’s ratio. It is found that patients on 
immunosuppressive drug are 12 times at risk of 
developing VAP than patients who are not on 
immunosuppressive drugs. 
Findings related to the association between 
clinical data- presence of pre-operative antibiotics 
in the patients & incidence of VAP. 
In order to determine association between 
intake of pre operative antibiotics and incidence of 
VAP, chi square test of significance was 
computed. Data presented in the Table 10 shows 
that 88.9 patient’s % of VAP who developed VAP 
were on preoperative antibiotics while only 19% 
of patients without VAP had preoperative 
antibiotics.  
In order to determine association between 
intake of pre operative antibiotics and incidence of 
VAP, chi square test of significance was 
computed. It was found that the obtained chi 
square value was   significant at 0.001. it is 
interpreted that there is association between 
selected clinical data - preoperative antibiotics 
intake and incidence of VAP. The risk ratio for the 
intake of pre operative antibiotics is established by 
computing the Odd’s ratio. It is found that, patient 
patients on pre operative antibiotics are 34 times 
more prone to develop VAP than patients who are 
not on pre operative antibiotics. 
Findings related to the association between 
clinical data -peptic ulcer prophylaxis in the 
patients & incidence of VAP. In order to 
determine association between peptic ulcer 
prophylaxis and incidence of VAP, chi square test 
of significance was computed. 
The presented in the table 11 depicts that 77.8 
5 % & 22.2 % of patients with VAP had H2 
receptor antagonist & proton pump inhibitor 
respectively for peptic ulcer prophylaxis. While, 
47.6 % & 14.28 & of patients without VAP had H2 
receptor blocker & proton pump inhibitor for 
peptic ulcer prophylaxis. In order to determine 
association between peptic ulcer prophylaxis and 
incidence of VAP, chi square test of significance 
was computed. It was found that the obtained chi 
square value was not significant at 0.05 level.  
Findings related to the association between 
clinical data - duration of mechanical ventilation 
& incidence of VAP. 
In order to determine the association between 
duration of mechanical ventilation and incidence 
of VAP, chi square test of significance was 
computed  
From table 12, it can be noted that all patients 
(100%) who developed VAP were ventilated for 
time duration of 6-10 days but among patients who 
did not develop VAP, only 4.76% were ventilated 
for the same duration. 
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Table 10. Frequency distribution, percentage, chi square value and ‘p’ value of clinical data- presence of 
pre-operative antibiotics in the patients & incidence of VAP. 
Clinical data: Pre 
operative antibiotics 
With VAP Without VAP 
df χ 2 ‘p’ value f % f % 
Present 8 88.9 4 19 1 12.804 0.000*** Absent 1 11.1 17 81  
*** Significant at 0.001 level. 
Table 11. Frequency distribution, percentage, chi square value and ‘p’ value of presence of                 
peptic ulcer prophylaxis in the patients & incidence of VAP (n=30) 
Clinical data With VAP Without VAP df χ 2 ‘p’ value f % f % 
H2 receptor antagonist         
Present 7 77.8 10 47.6 1 2.334 0.127 
Proton pump inhibitors         
Present 2 22.2 3 14.28 1 0.29 0.59 
Table 12. Frequency distribution, percentage, chi square value and ‘p’value of clinical data - duration of 
mechanical ventilation & incidence of VAP & incidence of VAP. 
Clinical data: Duration 
of mechanical ventilation 
(days) 
With VAP Without VAP 
df χ 2 ‘p’ value 
f % f % 
2-5 0 0 20 95.33 
1 26.825 0.000*** 
6-10 9 100 1 4.76 
*** Significant at 0.001 level. 
Table 13. Frequency distribution, percentage, chi square value and ‘p’ value of mortality of patients & 
incidence of VAP. 
Morality  With VAP Without VAP df χ 2 ‘p’ value f % f % 
Death           
Present  8 88.9 4 19 1 12.804 0.000*** 
Absent  1 11.1 17 81    
   ***Significant at 0.001 level 
It was noted that, among the patients who 
developed VAP, 77.77 %had late onset pneumonia 
(after 5 of mechanical ventilation) & 22.2 % had 
early onset pneumonia (within 5 days of 
mechanical ventilation). 
In order to determine the association between 
duration of mechanical ventilation and incidence 
of VAP, chi square test of significance was 
computed. It was found that the obtained chi 
square value was significant at 0.001.  
Findings related to the association between 
mortality & incidence of VAP.  
In order to determine association between 
mortality of patients &incidence of VAP, chi 
square test of significance was computed. 
The data presented in table 13 reveal that, 
mortality of patients with VAP was 88.9% while it 
was only 19% in patients without VAP. In order to 
determine the association between incidence of 
VAP and mortality, chi square value was 
computed. It was found that the obtained chi 
square value was significant at 0.001. On 
computation of risk ratio, it was found that 
mortality is 34 times higher among patients with 
VAP than patients without VAP.    
The incidence of ventilator associated 
pneumonia was estimated to be 30%. Head injury 
together with cervical spine injury was found to be 
an independent risk factor for VAP development 
in the present study. Associated injuries and 
additional surgery were found to be risk factor for 
the development of VAP and it was also found 
that patients with associated injuries are 10 times 
more prone to develop VAP than non VAP 
patients in the present study.  66.7% of patients 
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who developed VAP were on immuno suppressive 
drug while only 14.3 % patients who were free of 
VAP were on immunosuppressive drugs. Present 
study revealed that immunosuppressive drug 
intake was found to be a significant factor for the 
development of VAP, & the risk is 12 times more 
when compared to patients who were not on 
immunosuppressant. Pre-operative antibiotics 
were present in 88.9% of VAP patients & 19% of 
non VAP patients had pre-operative antibiotics. 
Significant relationship between pre-operative 
antibiotics & incidence of VAP was found out in 
the present study. The risk of VAP in patients 
receiving pre-operative antibiotics found to be 34 
times more than patients who were not on pre-
operative antibiotics. 100%of patients who 
developed VAP were on mechanical ventilator for 
time duration of 6-10 days. It was found that there 
is significant relationship between duration of 
mechanical ventilation and incidence of VAP. 
Mortality among patients with VAP was 88.9% 
while it was 19% in patients without VAP. In the 
present study, it was found that VAP had 
significant association with the mortality (OR-34 
times higher in VAP patients than patients without 
VAP).  
Discussion 
David et al. (2004) in their study on ventilator 
associated pneumonia in traumatic brain injury 
reported that the incidence rate was 42%. The 
incidence density of VAP was reported to be 
28.6% in the neurosurgery intensive care unit of 
University Hospital Athens (Apostolopouloc, 
2005). In the present study the incidence of 
ventilator associated pneumonia was estimated to 
be 30 %.and this finding is consistent with the 
previous investigators. Every patient who is 
intubated and receiving ventilatory support is at 
risk for VAP. Risk factor identification is a critical 
step in the prevention of ventilator associated 
pneumonia. Risk factors as identified by Tejada & 
Bello (2003) in critically ill trauma patients were 
nasogastric feeding, prolonged mechanical 
ventilation (>1 day), use of H2 receptor  
antagonist, muscle relaxants, corticosteroids, 
barbiturates, craniotomy, intense sedation. In the 
present study, the risk factor that demonstrated 
significant association with incidence of VAP 
were  combined head and cervical injury (P = 
0.001) ,poly trauma (P = 0.035), additional surgery 
(P = 0.025), nasogastric  feeding (P = 0.001), 
corticosteroids (P = 0.004), pre- operative 
antibiotics (P = 0.000) ,duration of mechanical 
ventilation >5 days (P = 0.000). Similarly Hugues, 
Oliver, Benoit, Serge and Gilles (2006) identified 
that ICU admitting diagnosis, administration of 
antibiotics prior to ventilation, use of steroids 
invariably resulted in VAP development. Yet 
another study by David et al (2004) high lighted 
that poly trauma (risk ratio 1.7) & prolonged (>24 
hours) antibiotic treatment independently 
predicted late onset pneumonia (OR, 9.2). 
Conclusion 
Despite rapid technological and treatment 
advances in medicine, nosocomial infection rates 
remain elusive. VAP is a multifaceted process and 
will require innovative and comprehensive 
approaches to all possible aspects of prevention.  It 
has been estimated that up to one-third of VAP 
could be prevented by improved infection control 
practice Prevention outcomes are directly related 
to reducing the risk. When   the actual treatment 
cost of VAP is considered,the cost effective 
method is to prevent VAP using guideline. 
Prevention involves planting a tree, nurturing it, 
pruining it and watching it grow and spread seeds 
for more trees. Investing in prevention can pay 
great dividends in terms of improved quality of 
life, morbidity and mortality. Spreading the seeds 
of prevention into long term care and 
rehabilitation facilities is also vitally needed.  
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